Close to NOK 1 billion for health research in 2013

Cancer research and mental health research received NOK 155 million and NOK 106 million, respectively, of the Research Council of Norway’s overall investment of almost NOK 1 billion in health-related research in 2013.

One-fourth of the research activity focused on aetiology, the study of causation of disease. Research on the development of treatments and therapeutic interventions was the next largest category.

The figures come from a portfolio analysis based on the Health Research Classification System (HRCS), which builds on WHO’s International Classification of Diseases. The Research Council has used the HRCS since 2011 in its statistics and analysis activities.

The analysis from 2013 encompasses both the Research Council’s active health-related projects and the efforts involved in establishing research centres in this area.


Cancer, mental health, infection and neurology on top

The HRCS analysis uses 21 health categories. Four of the largest categories in the Research Council’s health research portfolio are cancer (NOK 155 million), mental health (NOK 106 million), infection (NOK 93 million) and neurological research (NOK 88 million).

The largest category by far, however, is research with generic health relevance, which received about NOK 240 million in 2013. Public health research, epidemiology and health services research not targeted at a specific disease fall into this category, as do basic biological, psychosocial, economic or methodological studies not specific to an individual disease or condition.

Extensive research on the causation of disease

In addition to the health categories, the HRCS analysis uses eight categories of research activity to describe the type of research being conducted. These categories provide a more informative, detailed picture than the traditional way of categorising health research as either basic or applied. This is especially interesting with regard to applied research.   



Aetiology research comprises 25 per cent of the Research Council’s health research portfolio. The category encompasses research on the causes, risk and development of disease and poor health. The next largest research category is development of treatments and therapeutic interventions. This research is designed to develop new treatments and therapeutic methods, including testing in model systems and preclinical studies. 

Read more about the HRCS.

Associated companies:


 

Related news

Latest news

USCG confirms OPtimarin in Line for Ballast Water Approval

The United States Coast Guard (USCG) has confirmed that Norwegian ballast water treatment specialist Optimarin has become the first supplier to submit an application for type approval.

New order for Servogear

Servogear announces that they have received a new order from Brødrene Aa. 

Norwater AS reports boost in sales

The Norwater team reports of great interest and busy days in 2016. In a press release, they state that as of the first 8 months of the year, 2016 sales are already beyond target for the year as a whole.

Gaia-facts reaching ground control

The European Space Agency (ESA) has released the first data from the Gaia mission, which has the tremendous task of building the most precise 3D map of the Milky Way.

Polish delegation for Norwegian circular waste management

Against the background of the EU's ambitious waste management targets, Norwegian and Polish stakeholders met on Wednesday 14 September in Drammen.

Milestone at Mongstad Water Treatment Plant

SAR AS reports that an extensive upgrade to the water treatment plant at Mongstad reached a new milestone July. 

Servogear signs new contract with Özata Shipyard

Servogear has announced the signing of a new contract with Özata Shipyard in Turkey. The contract includes the delivery of Servogear Ecoflow PropulsorTMfor two 39 meter passenger catamarans (YN 41 & YN 42).

Statoil and Petrobras strengthen strategic partnership

Statoil reports that they have strengthened their cooperation in Brazil by signing a Memorandum of Understanding (MoU) with Petrobras.

TechInvent and Island Offshore/Centrica announced winners of ONS Innovation Award

TechInvent and Island Offshore/Centrica were announced winners of the ONS 2016 Innovation Awards, at the Innovation Awards Ceremony Tuesday 30 August.